Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001659617-19-000101
Filing Date
2019-07-15
Accepted
2019-07-15 16:04:42
Documents
1
Period of Report
2019-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156322106686428.html 4  
1 FORM 4 wf-form4_156322106686428.xml 4 4117
  Complete submission text file 0001659617-19-000101.txt   5502
Mailing Address 2450 SOUTH SHORE BLVD. SUITE 402 LEAGUE CITY TX 77573
Business Address
Foster Jonathan P. (Reporting) CIK: 0001545414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 19955243

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations